Outlook On Ohio Revised To Stable Based On Structural Budget Balance Progress Jul 11

  • ID: 2025764
  • July 2011
  • Region: Ohio
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) July 15, 2011--Standard & Poor's Ratings Services revised its outlook to stable from negative on the 'AA+' rating on Ohio's general obligation (GO) bonds. The outlook revision reflects the state's progress in restoring structural budget balance through fiscal 2013 and the modest economic recovery underway, which has stabilized revenues. At the same time, we assigned a 'AA+' long-term rating to Ohio's $416.75 million GO refunding bonds. The rating reflects our view of: Ohio's long track record of proactive financial and budget management, including its implementation of frequent and timely budget adjustments over time to mitigate lower revenues; The availability of various reserves at the start of the recession, which has since allowed the state to...

Companies mentioned in this report are:
- Ohio

Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.